Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 216 entries
View as:

Laquinimod Phase IIa Study in Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00737932 Org: User:
Start: 05/31/10 End: 12/31/11 Due: 12/31/12

A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01270464 Org: User:
Start: 02/28/11 End: 09/30/13 Due: 09/30/14

Safety and Bioavailability of IV and SC LBR-101

Phase: N/A Priority: Normal
NCT ID: NCT01991509 Org: User:
Start: 10/31/13 End: 01/31/15 Due: 01/31/16

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00203008 Org: User:
Start: 01/31/03 End: 09/30/03 Due: 09/30/04

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

Phase: N/A Priority: Normal
NCT ID: NCT02184767 Org: User:
Start: 07/31/14 End: 05/31/15 Due: 05/31/16

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02025556 Org: User:
Start: 01/31/14 End: 03/31/15 Due: 03/31/16

Safety and Efficacy of Talampanel in Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00267592 Org: User:
Start: 12/31/05 End: 02/28/11 Due: 02/28/12

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)

Phase: N/A Priority: Normal
NCT ID: NCT00856635 Org: User:
Start: 02/28/09 End: 02/28/11 Due: 02/28/12

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Phase: N/A Priority: Normal
NCT ID: NCT01844869 Org: User:
Start: 07/31/13 End: 01/31/15 Due: 01/31/16

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT01178125 Org: User:
Start: 08/31/10 End: 01/31/13 Due: 01/31/14

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01922752 Org: User:
Start: 07/31/13 End: 12/31/15 Due: 12/31/16

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT03965091 Org: User:
Start: 07/31/19 End: 01/19/22 Due: 01/19/23

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02969408 Org: User:
Start: 02/13/17 End: 02/02/18 Due: 02/02/19

A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021

Phase: N/A Priority: Normal
NCT ID: NCT00544882 Org: User:
Start: 10/31/07 End: 03/31/08 Due: 03/31/09

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03308968 Org: User:
Start: 10/13/17 End: 05/29/19 Due: 05/29/20

A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Phase: N/A Priority: Normal
NCT ID: NCT00988052 Org: User:
Start: 11/10/09 End: 07/01/17 Due: 07/01/18

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00104091 Org: User:
Start: 12/31/04 End: 06/30/07 Due: 06/30/08

A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT01404117 Org: User:
Start: 03/31/12 End: 01/31/14 Due: 01/31/15

Study of TV-1106 in Growth Hormone-Deficient Adults

Phase: N/A Priority: Normal
NCT ID: NCT02410343 Org: User:
Start: 04/30/15 End: 12/31/15 Due: 12/31/16

A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01769677 Org: User:
Start: 01/31/13 End: 02/28/13 Due: 02/28/14

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03503318 Org: User:
Start: 04/27/18 End: 12/03/20 Due: 12/03/21

Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03256695 Org: User:
Start: 09/28/17 End: 04/17/18 Due: 04/17/19

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache

Phase: N/A Priority: Normal
NCT ID: NCT03107052 Org: User:
Start: 04/27/17 End: 06/11/19 Due: 06/11/20

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT00375219 Org: User:
Start: 09/20/06 End: 06/28/13 Due: 06/28/14

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02031640 Org: User:
Start: 12/31/13 End: 12/31/14 Due: 12/31/15